Chief Patent Counsel, Medtronic CardioVascular
David P. Ruschke will become the next Chief Judge of the Patent Trial and Appeal Board (PTAB) at the United States Patent and Trademark Office (USPTO) beginning May 26, 2016.
Prior to being appointed a Chief Judge of the PTAB, Ruschke had most recently been Chief Patent Counsel of Medtronic CardioVascular located in Santa Rosa, CA, where he managed a team of 15 attorneys, agents, and paralegals, providing services and counseling on all matters related to intellectual property, including patent litigation, product clearances, patent prosecution, due diligence, mergers and acquisitions, licensing, third-party agreements, opinions, copyrights, and trademarks. Prior to his present position, David worked at Medtronic, Inc. at its world headquarters located in Minneapolis, MN, where he supported Medtronic’s Corporate Science and Technology division.
Previously, David was employed by the law firm of Covington & Burling in Washington, DC, where he engaged in patent litigation and prosecution, counseling, and opinion work in a variety of technical areas. David also clerked for the Honorable Arthur J. Gajarsa, Circuit Judge, and the Honorable Glenn L. Archer, Jr., former Chief Judge, of the United States Court of Appeals for the Federal Circuit.
David received his JD from Georgetown University Law Center (magna cum laude, Order of the Coif). He holds a PhD in organometallic chemistry from the Massachusetts Institute of Technology and a BS in chemistry from the University of Minnesota.
David is admitted to practice in Maryland, North Carolina, and the District of Columbia, and he is registered in-house counsel in California. He is also registered to practice before the United States Patent and Trademark Office. He is a member of AIPLA, ABA, ACS, Phi Beta Kappa, and Sigma Xi.